ABAC Therapeutics

While the demand for discovery and development of novel therapies to address drug-resistant infections has been clearly elucidated again and again, the big biopharmaceutical industry players continue

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bioph

The battle to find new antibiotics to replace those that are becoming increasingly ineffective against bacteria has been boosted by the launch of a $165m venture fund set up by Novo Holdings to addres

European biotechs in the antimicrobial resistance space are being hurt by the funding hurdles in schemes such as the Horizon 2020 research and innovation program, and are turning to the US for financi